Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer

NCT02767752 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

OTHER

Sponsor class

Stopped Poor accrual and change of SOC (FOLFIRINOX in adjuvant setting)

Conditions

Pancreatic Cancer

Interventions

DIETARY_SUPPLEMENT: T-ChOS
DRUG: Gemcitabine
DIETARY_SUPPLEMENT: Placebo
DRUG: Capecitabine

Sponsor

Herlev Hospital

Collaborators

[object Object]